|
(11) | EP 0 569 415 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | PHARMACEUTICAL COMBINATION FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS |